Back

Buspirone effect on chemoreflex and central apneas in heart failure

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Advanced heart failure Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Chiara Borrelli

University Hospital of Pisa, Pisa (Italy)

6 More presentations in this session

Presentation thumbnail
Predicting 30-day mortality and 30-day re-hospitalization risks in patients with heart failure
Professor G. Gambassi (Rome, IT)
Abstract Slides
Presentation thumbnail
Vagus nerve stimulation for chronic heart failure: differences in therapy delivery and clinical efficacy in ANTHEM-HF, INOVATE-HF, and NECTAR-HF
Doctor I. Libbus (Houston, US)
Abstract
Presentation thumbnail
Cardiac contractility modulation provides improved ventilatory efficiency and reduces oscillatory breathing pattern
Doctor D. Schoene (Gelsenkirchen, DE)
Abstract Slides
Presentation thumbnail
Biomechanic and neuroautonomic adaptation to acute blood volume displacement in patients with ischemic dilated cardiomyopathy
Professor M. Ciccone (Bari, IT)
Abstract Slides
Presentation thumbnail
Heart Failure hospitalization and mortality in non-valvular Atrial Fibrillation: The ENGAGE-AF TIMI 48 Trial
Doctor R. Inciardi (Brescia, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Advanced heart failure

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources